Clinical Cancer Research

Journal Title：Clinical Cancer Research

Clinical Cancer Research publishes innovative clinical and translational cancer research studies that bridge the laboratory and the clinic. The Journal is especially interested in clinical trials evaluating new treatments, accompanied by research on pharmacology, and molecular alterations or biomarkers that predict response or resistance to treatment. The Journal also prioritizes laboratory and animal studies of new drugs and molecule-targeted agents with the potential to lead to clinical trials, and studies of targetable mechanisms of oncogenesis, progression of the malignant phenotype, and metastatic disease.

Specific areas of interest include clinical and translational research in targeted therapies; mechanisms of drug sensitivity and resistance; pharmacogenetics and pharmacogenomics; personalized medicine; novel applications of bioinformatics and biostatistics; immunotherapy and clinical immunology; gene therapy; radiobiology and radiation oncology; large-scale molecular characterization of human tumors; diagnostic biomarkers; innovative imaging and other novel methods with potential applicability to clinical investigation; clinical genetics; and detection of minimal disease.

《临床癌症研究》发表创新的临床和转化癌症研究，将实验室和临床联系起来。该期刊特别关注评估新疗法的临床试验，以及药理学研究、预测治疗反应或耐药性的分子改变或生物标记物。该期刊还优先考虑可能进行临床试验的新药和分子靶向药物的实验室和动物研究，以及针对癌变、恶性表型进展和转移性疾病的靶向机制的研究。

具体感兴趣的领域包括靶向治疗的临床和转化研究；药物敏感性和耐药性的机制；药物遗传学和药物基因组学；个性化医疗；生物信息学和生物统计学的新应用；免疫疗法和临床免疫学；基因治疗；放射生物学和放射肿瘤学；人类肿瘤的大规模分子表征；诊断性生物标记物；创新成像和其他可能适用于临床研究的新方法；临床遗传学；以及最小疾病的检测。

Clinical Cancer Research创刊于1995年，由American Association for Cancer Research Inc.出版商出版，收稿方向涵盖医学 - 肿瘤学全领域，在行业领域中学术影响力很大，属于TOP期刊，国际一流期刊，关注度和专业度非常高，所以对原创文章要求创新性很高，过审难度很高，如果您有志于TOP期刊，建议关注此刊。平均审稿速度 约2.1月 ，影响因子指数10，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。